Combined production of TNF-α and IFN-γ from CD4 T cells has been shown to alter the tumor microenvironment sensitizing tumors to various types of chemotherapy, such as treatment with cyclophosphamide and 5-fluorouracil [51]. The gene discussed is CD4; the disease is neoplasm.